NCT06700356Recruiting
Thalamus Seizure Detection With a Deep Brain Stimulator System
Seizure Detection With a Deep Brain Stimulation System
Source: ClinicalTrials.gov · Last updated 13 Jul 2026
Brief summary (registry, in English)
The purpose of this study is to determine the feasibility of chronic ambulatory thalamus seizure detection. The sensitivity, specificity, and false alarm rate of thalamus seizure detection will be calculated using recordings from a deep brain stimulation system, assessed relative to concurrent gold-standard video-EEG monitoring collected in the in-patient setting (epilepsy monitoring unit), in 5 patients with drug resistant epilepsy.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 5 (estimated)
- First submitted
- 20 Nov 2024
- Start date
- 1 Jul 2026
- Primary completion date
- Nov 2026
- Lead sponsor
- Mayo Clinic
- Diseases
- Epilepsy
- NCT number
- NCT06700356
What you commit to
- Study type: Interventional
- Planned participants: 5
- From 1 Jul 2026 to the primary completion date, Nov 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with adherence to study requirements.
Other illness
- Health status or any clinical conditions (e.g., life expectancy, co-existing disease) that, in the opinion of the site investigator, would pose undue risk to undergo epilepsy monitoring unit evaluation for the purpose of seizure characterization.
Other
- All candidates meeting any of the exclusion criteria at baseline will be excluded from study participation:
- Women will verify not pregnant, and if applicable, have urine pregnancy test.
- Inability or unwillingness of individual or legal guardian/representative to give written informed consent.
Who the study is looking for
- Participants must meet all of the inclusion criteria to participate in this study:
- 18 years of age and older.
- Implanted with a clinical DBS system for epilepsy with brain recording capabilities (Medtronic Percept™ DBS).
- Subject or legally authorized representative is able to understand study procedures and to comply with them for the entire length of the study.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic in Rochester Coordinator of this site? Confirm its status | Rochester | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.